Dow Down 0.26% Nasdaq Down 0.90%

ARCA biopharma, Inc. (ABIO)

-NasdaqCM
1.26 Down 0.03(2.33%) 10:21AM EDT - Nasdaq Real Time Price
Prev Close:1.29
Open:1.29
Bid:1.26 x 700
Ask:1.27 x 300
1y Target Est:3.75
Beta:2.1
Next Earnings Date:N/A
Day's Range:1.25 - 1.29
52wk Range:1.19 - 2.54
Volume:28,552
Avg Vol (3m):147,194
Market Cap:26.47M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ABIO

Comparison

Symbol% ChgMkt Cap
ABIODown 2.33%26.47M
AZNUp 0.09%94.46B
GSKUp 0.38%114.24B
ILIU 0.00%19.61M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatm... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback